Clinical and preclinical study correlation for SYL1001, a new treatment for dry eye disease

被引：0
|
作者：
Gonzalez, Victoria [1 ]
Ruz, Veronica [2 ]
Paneda, Covadonga [3 ]
Bleau, Anne-Marie [1 ]
Vargas, Beatriz [2 ]
Isabel Jimenez, Ana [3 ]
机构：
[1] Sylentis, Clin, Tres Cantos, Madrid, Spain
[2] Sylentis, Regulatory Affairs, Tres Cantos, Madrid, Spain
[3] Sylentis, R&D, Tres Cantos, Madrid, Spain
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2017年 / 58卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
2670
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Efficacy of SYL1001 in different animal models of Dry Eye Disease
    Isabel Jimenez, Ana
    Paneda, Covadonga
    Martinez, Tamara
    Guerra, Amor
    Fonseca, Nuno
    Monteiro, Susana
    Salvador, Cristian
    Merayo-Lloves, Jesus
    Alcalde, Ignacio
    Ruz, Veronica
    Gonzalez, Victoria
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [2] Stability study of SYL1001 eye drops (a siRNA compound) for Dry Eye Disease in different containers
    Ruz, Veronica
    Ruiz, Yolanda
    Astrain, Carlos
    Segura, Carlos
    Miguel, Noelia
    Millan, Carlos
    Gonzalez, Victoria
    Company, Maria D.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [3] Safety and Efficacy Clinical Trials for SYL1001, a Novel Short Interfering RNA for the Treatment of Dry Eye Disease
    Benitez-Del-Castillo, Jose Manuel
    Moreno-Montanes, Javier
    Jimenez-Alfaro, Ignacio
    Munoz-Negrete, Francisco Jose
    Turman, Krista
    Palumaa, Kadi
    Sadaba, Belen
    Gonzalez, Maria Victoria
    Ruz, Veronica
    Vargas, Beatriz
    Paneda, Covadonga
    Martinez, Tamara
    Bleau, Anne-Marie
    Jimenez, Ana Isabel
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (14) : 6447 - 6454
  • [4] SYL1001, a new treatment based on RNAi for the treatment of ocular pain.
    Ruz, Veronica
    Gonzalez, Victoria
    Martinez-Garcia, Carmen
    Paneda, Covadonga
    Isabel Jimenez, Ana
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [5] Preclinical study of a new matrix to help the ocular surface in dry eye disease
    Abbate, Ilenia
    Zappulla, Cristina
    Santonocito, Manuela
    Viola, Santa
    La Rosa, Luca Rosario
    De Pasquale, Giuseppe
    Caviola, Elisa
    Meloni, Marisa
    Curatolo, Maria Cristina
    Mazzone, Maria Grazia
    EXPERIMENTAL EYE RESEARCH, 2022, 222
  • [6] Clinical evaluation of new canalicular insert for treatment of dry eye disease
    Tran, William
    Curry, Kenneth
    Voskanyan, Lilit A.
    Stephens, Kerry G.
    Usner, Dale
    Kothe, Angela C.
    Katz, L. Jay
    Holland, Jeffrey Ray
    Alvarado, Reesha Faye
    Parizadeh, Dari
    Zheng, Kun
    Lehto, Carol
    Arden, Katelyn
    Navratil, Tomas
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
  • [7] Correlation of Measures From the OCULUS Keratograph and Clinical Assessments of Dry Eye Disease in the Dry Eye Assessment and Management Study
    Sutphin, John E.
    Ying, Gui-shuang
    Bunya, Vatinee Y.
    Yu, Yinxi
    Lin, Meng C.
    McWilliams, Kathleen
    Schmucker, Elizabeth
    Kuklinski, Eric J.
    Asbell, Penny A.
    Maguire, Maureen G.
    CORNEA, 2022, 41 (07) : 845 - 851
  • [8] New drugs for the treatment of dry eye disease
    Ridder, William H., III
    Karsolia, Apoorva
    CLINICAL OPTOMETRY, 2015, 7 : 91 - 102
  • [9] A new look at dry eye disease and its treatment
    J. Daniel Nelson
    Harold Helms
    Richard Fiscella
    Yvonne Southwell
    Jan D. Hirsch
    Advances in Therapy, 2000, 17 : 84 - 93
  • [10] Tivanisiran, a new treatment for Dry Eye Disease, that improved signs and symptoms in clinical trials
    Jimenez, Ana Isabel
    Ruz, Veronica
    Gonzalez, Victoria
    Paneda, Covadonga
    Martinez, Tamara
    Vargas, Beatriz
    Bleau, Anne Marie
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
12345